Could a patent infringement case filed against Pfizer just before the holiday help Elan CEO Kelly Martin in his negotiations with Wyeth over revenues from bapineuzamab, his Alzheimer's drug? The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results